Ethanol and its metabolite acetaldehyde increase transforming growth factor beta1 (TGF-beta1) expression in animal studies. TGF-beta1 is related with the hepatic stellate cell (the key element of hepatic fibrogenesis) and the radial glia (the key element of neuronal migration). Blood samples were collected from 41 patients with alcohol dependence, TGF-beta1 levels measured by ELISA were compared with 41 normal subjects. Plasma TGF-beta1 levels in the patients with alcohol dependence (1,653.11+/-532.45 pg/mL) were significantly higher than those of healthy subjects (669.87+/-366.53 pg/mL) (P=0.000). Patients with or without liver pathology showed no difference in TGF-beta1 (P=0.36). Increased TGF-beta1 may mediate deleterious effect of alcohol such as hepatic fibrosis and suppressed neuronal developments in alcohol dependence patients.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752781 | PMC |
http://dx.doi.org/10.3346/jkms.2009.24.5.941 | DOI Listing |
Epigenomes
December 2024
Department of Psychiatry, University of Iowa, Iowa City, IA 52246, USA.
Background: Heavy alcohol consumption (HAC) has a profound adverse effect on human health. Unfortunately, there is a relative lack of tools that are easily implementable in clinical settings and that can be used to supplement self-reporting in the diagnosis and management of HAC. In part, this paucity is due to limitations of currently available biological measures and a mismatch between available biological measures and the needs of clinicians managing HAC.
View Article and Find Full Text PDFFront Nutr
January 2025
Department of Infectious Diseases, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
Introduction: Wernicke encephalopathy is a metabolic disease mainly associated with vitamin B1 deficiency, which is common in chronic alcoholism. Non-alcoholic Wernicke encephalopathy is difficult for early diagnosis.
Case Presentation: One case involved a 62-year-old man who was admitted to hospital with drug-induced liver failure.
Front Med (Lausanne)
January 2025
VA Connecticut Healthcare System, West Haven, CT, United States.
[This corrects the article DOI: 10.3389/fmed.2023.
View Article and Find Full Text PDFPsychiatr Serv
January 2025
Department of Psychiatry, Geisel School of Medicine, Dartmouth College, and Department of Psychiatry, Dartmouth Health, Lebanon, New Hampshire.
Across the globe, psychiatric illnesses are common, painful, often disabling, and sometimes deadly. Although well-researched practices exist to address these disorders, most people with psychiatric illnesses do not have access to care that has been demonstrated to be effective. Practical clinical leadership experience and engagement in evidence-based practice (EBP) implementation research in Colombia and the United States have demonstrated that multisite EBP implementation is possible and that effective implementation improves outcomes for people who develop psychiatric illnesses.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!